Log In
BCIQ
Print this Print this
 

CHF 5407

  Manage Alerts
Collapse Summary General Information
Company Chiesi Farmaceutici S.p.A.
DescriptionM3 muscarinic antagonist
Molecular Target Muscarinic acetylcholine receptor M3 (CHRM3) (HM3)
Mechanism of ActionMuscarinic acetylcholine receptor M3 antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today